Effects of propofol on nociceptive response and power spectra of electroencephalographic and systemic arterial pressure signals in the rat: Correlation with plasma concentration

Chen Hsein Yang, M. H. Shyr, T. B.J. Kuo, P. P.C. Tan, S. H.H. Chan

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

We applied simultaneous spectral analysis of electroencephalographic (EEG) and systemic arterial pressure signals in Sprague-Dawley rats to monitor the status of consciousness and cardiovascular functions during intravenous anesthesia with propofol and to assess their correlations with plasma propofol concentration. Our results support the hypothesis that a 'threshold' plasma concentration (1.7-1.8 μg/ml) exists for propofol anesthesia. This threshold level, we further showed, may be attained by both i.v. bolus injection and continuous infusion, although the pharmacokinetic profiles, as well as EEG and hemodynamic correlates, may be different. Continuous, on- line power spectral analysis of EEG signals revealed that the degree of reduction in the power density of the θ and δ bands and root mean square value paralleled the level of anesthesia. Significant suppression of both α and β components occurred only concomitant with EEG burst suppression. At the subanesthetic dose, i.v. infusion of propofol increased preferentially the power density of the θ and δ bands, suggesting the validity of including sedation as a nonhypnotic therapeutic application of propofol. We also found that appreciable cardiovascular suppression took place only upon anesthetic doses of propofol. Power spectral analysis of systemic arterial pressure signals indicated that this was accompanied by a progressive depression of spectral parameters that signify peripheral vascular resistance and baroreceptor reflex response.

Original languageEnglish
Pages (from-to)1568-1574
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume275
Issue number3
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Propofol
Arterial Pressure
Vascular Resistance
Consciousness Monitors
Anesthesia
Intravenous Anesthesia
Baroreflex
Sprague Dawley Rats
Anesthetics
Pharmacokinetics
Hemodynamics
Injections
Power (Psychology)

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

@article{ca20abf8410c4edd867ebec73723ccd2,
title = "Effects of propofol on nociceptive response and power spectra of electroencephalographic and systemic arterial pressure signals in the rat: Correlation with plasma concentration",
abstract = "We applied simultaneous spectral analysis of electroencephalographic (EEG) and systemic arterial pressure signals in Sprague-Dawley rats to monitor the status of consciousness and cardiovascular functions during intravenous anesthesia with propofol and to assess their correlations with plasma propofol concentration. Our results support the hypothesis that a 'threshold' plasma concentration (1.7-1.8 μg/ml) exists for propofol anesthesia. This threshold level, we further showed, may be attained by both i.v. bolus injection and continuous infusion, although the pharmacokinetic profiles, as well as EEG and hemodynamic correlates, may be different. Continuous, on- line power spectral analysis of EEG signals revealed that the degree of reduction in the power density of the θ and δ bands and root mean square value paralleled the level of anesthesia. Significant suppression of both α and β components occurred only concomitant with EEG burst suppression. At the subanesthetic dose, i.v. infusion of propofol increased preferentially the power density of the θ and δ bands, suggesting the validity of including sedation as a nonhypnotic therapeutic application of propofol. We also found that appreciable cardiovascular suppression took place only upon anesthetic doses of propofol. Power spectral analysis of systemic arterial pressure signals indicated that this was accompanied by a progressive depression of spectral parameters that signify peripheral vascular resistance and baroreceptor reflex response.",
author = "Yang, {Chen Hsein} and Shyr, {M. H.} and Kuo, {T. B.J.} and Tan, {P. P.C.} and Chan, {S. H.H.}",
year = "1995",
language = "English",
volume = "275",
pages = "1568--1574",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Effects of propofol on nociceptive response and power spectra of electroencephalographic and systemic arterial pressure signals in the rat

T2 - Correlation with plasma concentration

AU - Yang, Chen Hsein

AU - Shyr, M. H.

AU - Kuo, T. B.J.

AU - Tan, P. P.C.

AU - Chan, S. H.H.

PY - 1995

Y1 - 1995

N2 - We applied simultaneous spectral analysis of electroencephalographic (EEG) and systemic arterial pressure signals in Sprague-Dawley rats to monitor the status of consciousness and cardiovascular functions during intravenous anesthesia with propofol and to assess their correlations with plasma propofol concentration. Our results support the hypothesis that a 'threshold' plasma concentration (1.7-1.8 μg/ml) exists for propofol anesthesia. This threshold level, we further showed, may be attained by both i.v. bolus injection and continuous infusion, although the pharmacokinetic profiles, as well as EEG and hemodynamic correlates, may be different. Continuous, on- line power spectral analysis of EEG signals revealed that the degree of reduction in the power density of the θ and δ bands and root mean square value paralleled the level of anesthesia. Significant suppression of both α and β components occurred only concomitant with EEG burst suppression. At the subanesthetic dose, i.v. infusion of propofol increased preferentially the power density of the θ and δ bands, suggesting the validity of including sedation as a nonhypnotic therapeutic application of propofol. We also found that appreciable cardiovascular suppression took place only upon anesthetic doses of propofol. Power spectral analysis of systemic arterial pressure signals indicated that this was accompanied by a progressive depression of spectral parameters that signify peripheral vascular resistance and baroreceptor reflex response.

AB - We applied simultaneous spectral analysis of electroencephalographic (EEG) and systemic arterial pressure signals in Sprague-Dawley rats to monitor the status of consciousness and cardiovascular functions during intravenous anesthesia with propofol and to assess their correlations with plasma propofol concentration. Our results support the hypothesis that a 'threshold' plasma concentration (1.7-1.8 μg/ml) exists for propofol anesthesia. This threshold level, we further showed, may be attained by both i.v. bolus injection and continuous infusion, although the pharmacokinetic profiles, as well as EEG and hemodynamic correlates, may be different. Continuous, on- line power spectral analysis of EEG signals revealed that the degree of reduction in the power density of the θ and δ bands and root mean square value paralleled the level of anesthesia. Significant suppression of both α and β components occurred only concomitant with EEG burst suppression. At the subanesthetic dose, i.v. infusion of propofol increased preferentially the power density of the θ and δ bands, suggesting the validity of including sedation as a nonhypnotic therapeutic application of propofol. We also found that appreciable cardiovascular suppression took place only upon anesthetic doses of propofol. Power spectral analysis of systemic arterial pressure signals indicated that this was accompanied by a progressive depression of spectral parameters that signify peripheral vascular resistance and baroreceptor reflex response.

UR - http://www.scopus.com/inward/record.url?scp=0029552958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029552958&partnerID=8YFLogxK

M3 - Article

C2 - 8531130

AN - SCOPUS:0029552958

VL - 275

SP - 1568

EP - 1574

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -